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double paradox exist in this patient cohort is not clear.
METHODS 5924 patients who underwent PCIs for ACS in two hospitals
were analyzed. Statistical analyses were performed to analyze the
respective relationship between smoking status and obesity (BMI >¼
30 kg/m2) and both in-patient and late mortality outcomes following
PCI. In addition, we used an interaction model to analyze the inter-
action between smoking and obesity on subsequent mortality
outcomes.
RESULTS Of the 5924 PCIs, 1086 were performed on patients who
were smokers. In unadjusted analyses, adverse late mortality out-
comes (mean 2.5 years follow-up) in smokers were signiﬁcantly lower
compared to non-smokers (p<0.01). After propensity score-adjust-
ment, late mortality was not signiﬁcantly different between the two
groups (HR 0.63, 95% CI 0.40-1.01, p¼0.06). Of the 5924 PCIs, 2076
were performed on patients who were obese. In unadjusted analyses,
adverse late mortality outcomes (mean 2.5 years follow-up) in obese
patients were signiﬁcantly lower than they were in non-obese patients
(p<0.01). After propensity score-adjustment, obese patients’ late
mortality outcomes were not signiﬁcantly different than patients with
BMI < 30 (HR 0.98, 95% CI 0.70 – 1.37). Furthermore, we found no
signiﬁcant interaction between smoking status and BMI on late mor-
tality (p¼0.82).
CONCLUSIONS We did not ﬁnd evidence of a smoker’s paradox,
obesity paradox or an obese-smoker double paradox for early and late
mortality outcomes post-PCI. Existence of such paradox in the prior
literature might be explained by confounding factors.
CATEGORIES CORONARY: PCI Outcomes
KEYWORDS Obesity, PCI - Percutanoeus Coronary Intervention,
Smokers paradox
TCT-456
Abstract Withdrawn
TCT-457
Assessment of Optimal Drug-Eluting Stent Expansion to prevent target
lesion revascularization with OCT guidance.
Yoshinori Sanuki,1 Shinjo Sonoda,2 Hironori Takami,3
Yoshitaka Muraoka,4 Yuki Tsuda,2 Masaru Araki,5 Yutaka Otsuji4
1university of occupational and environmental health, Japan,
Kitakyusyu, Japan; 2University of Occupational and Environmental
Health, Kitakyushu, Japan; 3University of Occupational and
Environmental Health, Japan, Kitakyushu, Japan; 4University of
Occupational and Environmental Health, Kitakyushu, Japan;
5University of Occupational and Environmental Health, Kitakyushu,
Japan
BACKGROUND Recent studies have demonstrated that optimal
coherence tomography (OCT) guided percutaneous coronary inter-
vention (PCI) was useful to prevent major adverse cardiac events after
PCI. However, optimal Drug-eluting stent (DES) expansion using OCT
has not been established yet. The aim of this study to assess optimal
DES expansion at post stenting to prevent target lesion revasculari-
zation (TLR) at 8-month follow-up.METHODS Until May 2015, we performed OCT guided DES implanta-
tion and 8 months follow-up coronary angiography in 91 patients.
There were 14 TLRs (15.4%) including 6 in-stent and 8 stent edge
restenosis (4 proximal, 4 distal). After excluding 1 stent edge reste-
nosis due to stent edge injury, 13 TLRs were analyzed in this study
(TLR, N¼13; non-TLR, N¼77). Lipid rich plaque (deﬁned by lipid
occupying S2 quadrants of the cross-section area), thin cap ﬁbroa-
theroma (TCFA ,deﬁned as lipid-rich plaque with ﬁbrous cap thickness
&65mm) , plaque calciﬁcation, and thrombus (deﬁned as an irregular
mass protruding into the lumen with dimension S200 mm) were
measured at pre PCI. Minimal stent area (MSA), % stent expansion,
stent symmetry, and tissue protrusion were measured at post PCI.
RESULTS There were no signiﬁcant differences in clinical character-
istics between groups, except age (TLR was younger than non-TLR;
6411 vs 719, P¼0.02). TCFA and lipid rich plaque were lower in TLR
than in non-TLR (7.7% vs 23%, P¼0.12; 30% vs 45%, P¼0.18). There
were no signiﬁcant differences in plaque calciﬁcation, thrombus, %
stent expansion, stent symmetry, and existence of tissue protrusion
between TLR and non-TLR (46% vs 54%; 0.33%, 15% vs 14%; 0.42%,
85.1%27.3% vs 96.5%28.5%, P¼0.13;0.850.08 vs 0.850.08,
P¼0.86; 30% vs 22%, P¼0.50). MSA was signiﬁcantly smaller in TLR
than in non-TLR (4.31.9 vs 5.71.6, P<0.01). On multivariable anal-
ysis, Age and MSA were independent predictors of TLR (OR 1.11, 95%
CI 1.02-1.24, P¼0.02; OR¼2.58: 95%CI 1.14-7.68, P¼0.04). The best cut-
off value to prevent TLR was 4.7mm2 (sensitivity 74%, speciﬁcity 77%,
positive predict value 95%, negative predict value 33.3%).
CONCLUSIONS OCT guided DES expansion during PCI may be useful
to prevent TLR. The optimal MSA at post procedure to prevent TLR
was 4.7mm2.
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BACKGROUND Indication of side branch (SB) intervention after main
vessel (MV) stenting is not established in coronary bifurcation lesions.
This study sought to investigate differential effect of SB intervention
on long-term clinical outcomes according to SB stenosis after MV
stenting.
METHODS In the Coronary Bifurcation Stenting II Registry, 2,897 pa-
tients undergoing percutaneous coronary intervention using drug-
eluting stents for bifurcation lesions with SB 2.3 mm were enrolled.
We selected 2,017 patients treated with 1-stent technique or MV
stenting ﬁrst strategy. Patients undergoing SB intervention after MV
stenting (SB intervention group, n¼929) were compared to those not
after MV stenting (no-SB intervention group, n¼1,088) in terms of
cardiac death or myocardial infarction (MI).
RESULTS During a median follow-up duration of 37 months, the cu-
mulative rate of cardiac death or MI tended to occur less frequently in
the SB intervention group than in the no-SB intervention group (1.8 %
versus 2.9%; adjusted HR 0.56; 95% CI 0.29 to 1.07; p¼0.08). There
was signiﬁcant interaction between SB intervention and SB stenosis
after MV stenting. Of 1,077 patients with diameter stenosis of SB 50%
after MV stenting, SB intervention was associated with a lower risk of
cardiac death or MI (1.2% versus 4.2%; adjusted HR 0.22; 95% CI 0.09
to 0.52; p¼0.001). However, among 940 patients with diameter ste-
nosis of SB <50%, there was no signiﬁcant difference in cardiac death
or MI (3.5% versus 2.2%; adjusted HR 1.36; 95% CI 0.58 to 3.20;
p¼0.48) between the SB intervention group and the no-SB interven-
tion group. Rate of target lesion revascularization was not signiﬁ-
cantly different between the 2 groups regardless of SB stenosis.
CONCLUSIONS Effect of SB intervention differs according to SB ste-
nosis after MV stenting. SB intervention may reduce cardiac death or
MI in bifurcation lesions with diameter stenosis of SB 50% after MV
stenting.
CATEGORIES CORONARY: PCI Outcomes
KEYWORDS Bifurcation lesion, Side branch, Stenosis
